|

Targeted Therapy Agent (Fruquintinib) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Shandong Cancer Hospital and Institute1

Indications

  • Liver Disease1
  • Targeted Therapy1
  • Liver Metastasis1
  • Radiotherapy1
  • Immunotherapy1

Other1 trial

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.